1. A Comparison of PMDA and EMA Consultations for Regulatory and Scientific Matters in Drugs and Regenerative Medicine Products. (May 2017) Authors: Kondo, Hideyuki; Sugita, Toshiki; Ida, Naoko; Fukushima, Hiroko; Yasuda, Naoyuki Journal: Therapeutic innovation & regulatory science Issue: Volume 51:Number 3(2017:May) Page Start: 355 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Regulatory/Scientific Supports for Micro-, Small-, and Medium-Sized Enterprises (SMEs) With Medicinal Products Provided by the PMDA and EMA. (March 2019) Authors: Kondo, Hideyuki; Shibatsuji, Masayoshi; Yasuda, Naoyuki Journal: Therapeutic innovation & regulatory science Issue: Volume 53:Number 2(2019:Mar.) Page Start: 193 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. What to Know About Medicines With New Active Ingredients Approved in FY 2016 / 2016 in Japan and EU: A Brief Comparison of New Medicines Approved in Japan and the EU in 2016. (March 2018) Authors: Kondo, Hideyuki; Saint-Raymond, Agnès; Yasuda, Naoyuki Journal: Therapeutic innovation & regulatory science Issue: Volume 52:Number 2(2018:Mar.) Page Start: 214 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗